Latuda Oral Tablet 60Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

Latuda: Oral tablet (60mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Most Commonly Used
Drug Image file default-drug-image.png


What is this Medicine?

LURASIDONE (loo RAS i done) is an antipsychotic. It is used to treat schizophrenia or bipolar disorder, also known as manic-depression.

CVS/pharmacy Patient Statistics for Latuda: Oral tablet(60mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Latuda 60mg Tablet

NDC: 634020306
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Schizophrenia, Bipolar Depression

Sometimes used for but not FDA approved for the following conditions:
Agitation

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Latuda 60mg Tablet
Drug Image file DrugItem_18546.JPG
Sunovion Pharmaceuticals Inc. formerly Sepracor Inc.
Pill Identification: L 60 
Shape: oblong
Color: white

Reported Side Effects for Latuda 60mg Tablet

Kidney Failure Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Breast Pain Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Neuroleptic Malignant Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Thoughts Of Suicide Incidence:
<0.6%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Increase In Breast Size Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Dystonic Reaction Incidence:
<7.0%*
Severity: MODERATE
Onset: DELAYED
Galactorrhea Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
No Menstrual Periods Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Dysarthria Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Tardive Dyskinesia Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: EARLY
Heart Block Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: RAPID
Inflamed Stomach Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Menstrual Cramps Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
0.8-1.7%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Decreased Appetite Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Restlessness Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Extra Saliva Production Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Pseudoparkinsonism Incidence:
6.0-17.0%*
Severity: MODERATE
Onset: DELAYED
Restlessness Incidence:
6.0-22.0%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
15.0-26.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Latuda 60mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Latuda 60mg Tablet(Lurasidone HCl)
Grapefruit juice and Lurasidone HCl(Lurasidone HCl)
Grapefruit and Grapefruit juice should be avoided while taking Lurasidone. Grapefruit juice and grapefruit-containing foods may increase the effects of Lurasidone such as drowsiness, dizziness, restlessness, nausea, vomiting, tremor, muscle stiffness or spasms, anxiety, or other effects.
Major Lifestyle Interaction
Alcohol and Latuda 60mg Tablet(Lurasidone HCl)
Alcohol and Lurasidone HCl(Lurasidone HCl)
In general, you should avoid Alcoholic drinks while you are taking Lurasidone. Alcohol can affect the mood and interfere with the drug treatment, and may increase the risk of serious side effects. Decreased alertness, drowsiness, falls, or other side effects may occur. Do not drive or operate machinery if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Latuda

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.